Side-by-Side Comparison · 2026

Drosocin vs Pexiganan

Drosocin vs Pexiganan — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Drosocin
Antimicrobial Peptide

Drosocin is a 19-residue O-glycosylated proline-rich antimicrobial peptide from Drosophila melanogaster. It is a key component of the insect immune response triggered by Toll and Imd signaling pathways....

Calculate Drosocin dose →
Pexiganan
Antimicrobial Peptide

Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....

Calculate Pexiganan dose →
Key Parameters
Parameter Drosocin Pexiganan
Category Antimicrobial Peptide Antimicrobial Peptide
Research Preclinical Phase 3 (Failed 1999)
Half-Life Minutes (proteolytic) Hours (topical)
Typical Dose N/A 0.8% cream topically
Frequency N/A Twice daily
Route Research only Topical cream
FDA Status Not approved Not approved (failed Phase 3)

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate Drosocin Calculate Pexiganan
Frequently Asked Questions
What is the difference between Drosocin and Pexiganan?
Drosocin: Drosocin is a 19-residue O-glycosylated proline-rich antimicrobial peptide from Drosophila melanogaster. It is a key component of the insect immune response triggered by Toll and Imd signaling pathway... Pexiganan: Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later...
Which has a longer half-life, Drosocin or Pexiganan?
Drosocin half-life: Minutes (proteolytic). Pexiganan half-life: Hours (topical).
Can you stack Drosocin and Pexiganan?
Drosocin and Pexiganan are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.